https://doi.org/10.1016/s0149-2918(99)80045-9
K
Kerstin Malmström
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
34
Papers
3.0K
Citations
21
h-index
26
i10-index
Kerstin Malmström is an academic researcher from Merck & Co., Inc., Rahway, NJ, USA (United States). The author has contributed to research in topics: Asthma and respiratory diseases & Inflammatory mediators and NSAID effects & Respiratory and Cough-Related Research. The author has an h-index of 21, co-authored 29 publications.
Papers by this author
worksComparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: A randomized, placebo- and active-comparator-controlled clinical trial
1999 · Clinical Therapeutics · 261 citations
A comparison of rofecoxib versus celecoxib in treating pain after dental surgery: A single-center, randomized, double-blind, placebo- and active-comparator-controlled, parallel-group, single-dose study using the dental impaction pain model
2002 · Clinical Therapeutics · 70 citations
https://doi.org/10.1016/s0149-2918(02)80059-5
Etoricoxib Provides Analgesic Efficacy to Patients After Knee or Hip Replacement Surgery: A Randomized, Double-Blind, Placebo-Controlled Study
2005 · Anesthesia & Analgesia · 64 citations
https://doi.org/10.1213/01.ane.0000169294.41210.9e
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat